Find Academic Supervisors

Karen S. AndersonView profile

Professor

• Cancer Immunology
• Breast Cancer
• HPV-related Cancers
• +5 more

Karen S. Anderson, M.D., Ph.D. is a Professor of Medicine at Mayo Clinic in Phoenix, Arizona, where she serves as a Contract Physician in the Division of Hematology/Oncology within the Department of Internal Medicine. Her clinical practice focuses on breast cancer, and she is affiliated with the Mayo Clinic Comprehensive Cancer Center and the Breast Clinic. As an active researcher, Dr. Anderson leads clinical trials in breast cancer immunotherapy and biomarker development. Dr. Anderson's educational background includes: Medical Scientist Training Program (MD), Duke University School of Medicine (1994) Ph.D. in Microbiology and Immunology, Duke University (1994) BA in Chemistry, University of Virginia (1986) Internship and Residency in Internal Medicine, Brigham and Women's Hospital, Boston Fellowship in Adult Hematology and Oncology, Dana Farber Cancer Institute Dr. Anderson's research focuses on cancer immunology with particular emphasis on breast cancer biomarkers, ovarian cancer biomarkers, pancreatic cancer biomarkers, cancer vaccines, and HPV-related cancers. Her work spans from basic immunology to clinical applications, with a strong focus on translating laboratory findings into clinical practice. She has developed innovative approaches for early cancer detection and has been instrumental in advancing breast cancer immunotherapy through clinical trials. Analysis of Dr. Anderson's recent publications reveals a consistent focus on breast cancer immunology, biomarker discovery, and HPV-related cancers. Her work integrates molecular biology, immunology, and clinical oncology to develop novel diagnostic and therapeutic approaches. Notably, her research has expanded to include computational approaches for neoantigen prediction and has addressed public health challenges including HPV-related cancer screening and even COVID-19 vaccine strategies. Dr. Anderson has received several prestigious awards: Outstanding Faculty Mentor Arizona State University Faculty Women's Association (2020) Chief Resident West Roxbury VA Hospital (1996) Phi Beta Kappa University of Virginia (1986) Merck Scholar (1986) Alpha Omega Alpha Honor Medical Society (1986) Echols Scholar University of Virginia (1982) Dr. Anderson has been actively involved in mentoring students and early-career researchers, serving on numerous thesis committees at Arizona State University across multiple departments including Molecular and Cellular Biology, Chemistry, and the Barrett Honors College. Her research is supported by multiple grants from the National Cancer Institute, including her role as Co-Chair of the Breast and Gynecologic Cancers Collaborative Group within the Early Detection Research Network. Dr. Anderson is a key member of the Arizona Biomarker Alliance Executive Committee and has established collaborative research teams focused on cancer biomarker discovery and validation. Her laboratory work integrates protein microarray technology, immunology, and cancer genomics to develop novel diagnostic and therapeutic approaches for breast and HPV-related cancers.

• HIV Infection
• Viral Hepatitis
• Global Health Research
• +5 more

Robert L. Murphy is the John Philip Phair Professor of Infectious Diseases and Professor of Biomedical Engineering at Northwestern University. He directs the Institute for Global Health within the Institute for Public Health and Medicine. His roles include leadership in global health research, infectious disease management, and biomedical engineering. Murphy holds appointments in the Feinberg School of Medicine and McCormick School of Engineering. Education: MD from Loyola University Stritch School of Medicine (1978), Fellowship, Residency, and Board Certification in Internal Medicine at Northwestern University (1981–1984). Research focuses on HIV/AIDS, viral hepatitis, antiviral therapies, and global health disparities. He leads projects in Nigeria, Mali, and other regions, addressing liver fibrosis in HIV/HBV co-infection, cervical cancer in HIV-positive women, and SARS-CoV-2 diagnostics. His work emphasizes point-of-care technologies and epigenetic biomarkers for cancer and liver disease. Publications span over 40 years, with recent emphasis on Omicron variant dynamics, HPV screening in resource-limited settings, and microbiome impacts of antiretroviral therapy. He collaborates globally, co-leading studies on tuberculosis treatment and HIV/drug resistance patterns. Grants and collaborations include the BRAINS faculty development program in Africa, the Test Us Bank (TUB) biorepository for SARS-CoV-2 samples, and partnerships with institutions like the University of Lagos and the Robert H. Lurie Comprehensive Cancer Center.

Mark DignanView profile

Professor

• Cancer Screening
• Health Equity
• Community-Based Interventions
• +7 more

Mark Dignan, Ph.D., is a Professor with joint appointments in Behavioral Science, Internal Medicine, and the College of Social Work at the University of Kentucky. He contributes to the Cancer Prevention and Control Research Program, Center for Appalachian Research in Environmental Sciences (UK-CARES), and UNITE Research Priority Area, focusing on reducing health disparities in rural and underserved communities. Doctor of Philosophy, University of Tennessee-Knoxville (1977) Master of Public Health, University of North Carolina (1982) Master of Science, University of Utah (1974) Bachelor of Science, University of Utah (1973) His research evaluates community-based screening and early detection interventions, particularly for cervical, colorectal, and breast cancers. He specializes in health equity, tobacco control, and digital health strategies for rural populations, aligning with UN Sustainable Development Goals related to health and well-being. Recent work includes HPV self-collection programs, digital health interventions for colorectal cancer screening, and behavioral studies during the COVID-19 pandemic. His projects often involve collaborations with state health departments and the National Cancer Institute. R. Davilene Carter Presidential Prize for Best Manuscripts (2012, 2013, 2016, 2017, 2021) University Research Professor Award (2012) Current projects include statewide tobacco control evaluations and multi-institutional trials for cancer screening. He has led over 220 grants and 258 research outputs, emphasizing translational research and community engagement.

Chad J BrennerView profile

Associate Professor

• Head and Neck Cancer
• HPV-Driven Oncogenesis
• Liquid Biopsy Technologies
• +5 more

Dr. Chad J. Brenner is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery and Pharmacology at the University of Michigan Medical School. He also directs the U-M Program in Cellular and Molecular Biology, the Otolaryngology Clinical Laboratory (CLIA), and the Head & Neck Oncology Program. His research focuses on developing liquid biopsy tools for cancer detection and precision therapy, particularly in HPV-driven head and neck cancers. Key roles include membership in the Rogel Cancer Center, Kresge Hearing Research Institute, and Center for Computational Medicine & Bioinformatics. Education: B.S. in Biomedical Engineering, M.S. in Bioelectrical Engineering, and Ph.D. in Cellular and Molecular Biology from the University of Michigan, with doctoral work on prostate cancer mechanisms. Research Interests: HPV integration and cancer heterogeneity Urine- and blood-based liquid biopsies for real-time cancer monitoring Combination immunotherapy strategies for improving checkpoint inhibitor responses Genetic engineering to identify cancer vulnerabilities Clinical trial innovation for adaptive therapies Recent Work Highlights: Development of the MyHPVscore blood test for HPV-related head and neck cancer detection, and exploration of tumor-immune interactions through PD-L1 and T-cell profiling. Ongoing projects include PET-guided radiotherapy optimization and multi-omics analyses of tumor heterogeneity. Labs & Teams: Leads the Michigan Otolaryngology and Translational Oncology (MiOTO) lab and collaborates with interdisciplinary teams across computational medicine, immunology, and clinical oncology.

Xin LuView profile

Associate Professor

• Cancer Biology
• Tumor Microenvironment
• Tumor Immunology and Immunotherapy
• +12 more

Xin Lu is the John M. and Mary Jo Boler Collegiate Associate Professor in the Department of Biological Sciences at the University of Notre Dame. She is a full member of the Harper Cancer Research Institute (HCRI), the Boler-Parseghian Center for Rare and Neglected Diseases (CRND), and the Tumor Microenvironment and Metastasis Program at the Indiana University Simon Comprehensive Cancer Center. Her research spans tumor immunology, immunotherapy, metastasis, and multi-omics, with a focus on prostate, breast, and rare cancers. Ph.D. in Molecular Biology, Princeton University (2004–2010) B.S. in Biological Sciences, Tsinghua University, China (2000–2004) Postdoctoral Fellow, Dana-Farber Cancer Institute and M.D. Anderson Cancer Center (2010–2016) Assistant to Associate Professor, University of Notre Dame (2017–Present) Dr. Lu's research investigates the molecular and cellular mechanisms of tumor-immune crosstalk, particularly the role of myeloid-derived suppressor cells (MDSCs) and neutrophils in promoting immunotherapy resistance. Her lab uses genetically engineered mouse models, functional genomics, single-cell and spatial transcriptomics, and high-throughput screening to uncover novel therapeutic targets. A major focus is on how cancer-cell-intrinsic oncogenic signaling shapes the immunosuppressive tumor microenvironment. Her recent publications reveal mechanisms such as Acod1-mediated ferroptosis resistance in neutrophils, Pygo2-driven immunosuppression in prostate cancer, and the efficacy of ketogenic diets in overcoming checkpoint blockade resistance. These studies span multiple disciplines including cancer biology, immunology, metabolism, epigenetics, and bioengineering, reflecting a highly integrative approach to immuno-oncology. Jane Coffin Childs Postdoctoral Fellow John M. and Mary Jo Boler Faculty Appointment Cluster Chair, Cellular & Molecular Biology, IBMS PhD Program Junior Chair, Boler-Parseghian Center for Rare and Neglected Diseases Dr. Lu mentors a diverse team of graduate students, postdoctoral fellows, and undergraduates. Her lab is actively recruiting and has secured funding from federal agencies and private foundations. She collaborates with chemists, bioengineers, and bioinformaticians to develop novel therapeutics, including antibody-drug conjugates, CAR-NK cells, and small-molecule inhibitors. Her lab also develops innovative platforms like mini-tumor chips for immunotherapy evaluation. Her lab maintains affiliations with multiple interdisciplinary centers including the Warren Family Center for Drug Discovery, Eck Institute for Global Health, and Berthiaume Institute for Precision Health, underscoring her collaborative and translational research vision.

Stephanie B. WheelerView profile

Professor

• Cancer
• Health disparities/health equity
• Social epidemiology
• +5 more

Dr. Stephanie B. Wheeler is the Michael S. O’Malley Distinguished Professor in the Department of Health Policy and Management at the UNC Gillings School of Global Public Health. She serves as Associate Director of Community Outreach and Engagement at the UNC Lineberger Comprehensive Cancer Center and a Research Fellow at the UNC Center for Health Promotion and Disease Prevention. Her research focuses on cancer care delivery, health disparities, and systems science, with expertise in economic evaluation, simulation modeling, and large dataset analysis. Education: BA (Honors) in Theatre, College of Charleston, 2003 BS (Honors) in Biology, College of Charleston, 2003 MPH in Public Health and Family Medicine, University of Cape Town, 2007 PhD in Health Policy and Management, UNC-CH, 2010 Research Interests: Dr. Wheeler’s work addresses healthcare access, quality, value, and equity, particularly in cancer care. She uses methods like comparative effectiveness research, systems modeling, and 'big data' analytics to study cancer screening implementation, financial toxicity, and health policy interventions. Her projects are funded by NCI, the American Cancer Society, and CDC. Key Leadership Roles: Director of the Office of Community Outreach and Engagement, UNC Lineberger PI of the CDC-funded Cancer Prevention and Control Research Network Coordinating Center Co-Director of the NCI-funded T32 Cancer Care Quality Training Program Associate Editor, Journal of Clinical Oncology Awards: 2017 Hettleman Prize for Scholarly and Artistic Achievement 2017 ASPPH Early Career Award Grants & Projects: Leads/co-leads studies on colorectal cancer screening, financial navigation interventions, HPV vaccine communication, and cancer care quality surveillance. Her work emphasizes reducing disparities in rural and urban settings through evidence-based strategies. Labs & Teams: Active in the Gillings Innovation Labs and part of the Lineberger Equity Council, focusing on community-engaged research and policy translation.

• Adolescent health
• Child health
• Health services and management
• +2 more

Dr. Shingisai Chando is a Research Fellow at the Sydney School of Public Health within the Faculty of Medicine and Health at the University of Sydney. They hold degrees including BA, MA, MPH, DN, and PhD. Their research focuses on Indigenous health, child and adolescent health, health services management, and workforce dynamics, employing qualitative and translational research approaches. Key research interests include evaluating health programs for Aboriginal and Torres Strait Islander children, stakeholder engagement in health interventions, and addressing health disparities through policy and program design. They collaborate with interdisciplinary teams on projects such as the Study of Environment on Aboriginal Resilience and Child Health (SEARCH) and have contributed to understanding diagnostic practices in pediatric otitis media. No scientific awards are listed for Dr. Chando. Their work has been published in journals such as the Health Promotion Journal of Australia , Health Services Research , and Medical Journal of Australia . While no advising or grants are explicitly mentioned, their research demonstrates expertise in Indigenous health equity, child development, and healthcare system optimization.

Emily Annika BurgerView profile

Professor

• Health Economics
• Cancer Prevention
• Mathematical Modeling
• +3 more

Emily Annika Burger is a Professor at the Department of Health Management and Health Economics, University of Oslo, where she leads research on health economics and cancer prevention. She holds a PhD from the University of Oslo and maintains a joint appointment as Research Scientist at Harvard T.H. Chan School of Public Health. Her education includes an MPhil from the University of Oslo and a BS from the University of Denver. Her research applies mathematical modeling to evaluate health policies, with emphasis on HPV vaccination strategies, cervical cancer screening, and cost-effectiveness analyses in global health contexts. Primary interests include optimizing prevention programs, health technology assessment, and addressing healthcare disparities. Recent publications demonstrate a focus on modeling vaccination impacts during pandemics, health economic evaluations of cancer interventions, and innovative screening methodologies. Her work frequently employs microsimulation models to project long-term public health outcomes. Awards and Honors 2023 Cancer Society of Norway Young Researcher Award 2024 University of Oslo Award for Young Researchers She leads multiple international collaborations, including projects with the Cancer Registry of Norway and Harvard Chan School. Her research group focuses on economic evaluation methodologies for healthcare technologies.

Karen YeatesView profile

Professor

• Global Health
• Nephrology
• Cardiovascular Disease
• +5 more

Dr. Karen Yeates is a Professor in the Division of Nephrology at Queen's University's School of Medicine. She holds cross-appointments in the Faculty of Health Sciences and is a member of Queen's Cancer Research Institute and Translational Institute of Medicine. Her work focuses on improving healthcare access through mHealth innovations in global settings, particularly sub-Saharan Africa and Indigenous communities. Education: MD (Queen's University), MPH (Harvard School of Public Health), Fellowship in Nephrology (Royal College of Physicians and Surgeons Canada). Research interests span global health equity, cardiovascular disease prevention, cervical cancer screening, and mobile health technology. Key projects include leading the PURE Study Tanzania (Prospective Urban and Rural Epidemiology) and the International Polypill Study for cardiovascular prevention. She pioneered smartphone-based interventions for hypertension management in rural communities and cervical cancer screening in Tanzania. Articles consistently address mHealth implementation, chronic disease epidemiology, and health systems strengthening. Recent work evaluates mobile health tools for malaria prevention and cervical precancer detection in resource-limited settings. Rising Stars in Global Health Award (2024) CIHR-Global Alliance grant for mHealth hypertension projects Principal Investigator for Grand Challenges Canada initiatives Advocates for equitable kidney care globally, contributing to ISN Global Kidney Health Atlas. Co-founded Queen’s University School of Medicine’s Office of Global Health to advance interdisciplinary global health training.

Erin FinneranView profile

Senior Lecturer

• Irish Literary Modernism
• British Literary Modernism
• Modern Irish Drama
• +3 more

Erin Finneran is a Senior Lecturer in the Department of English at Washington University in St. Louis, with over 20 years of teaching experience. She specializes in Irish and British Literary Modernism, focusing on authors such as Samuel Beckett, Virginia Woolf, and Oscar Wilde. Her teaching spans courses like Ampersand: Literary Culture of Modern Ireland and Argumentation , emphasizing close reading and liberal arts education. Finneran holds a Ph.D. from Washington University, an M.A. from University College Dublin, and a B.A. from Kenyon College. Her academic career includes roles at both Washington University and University College Dublin. Research interests center on modernist literature, with a particular emphasis on parody in Beckett’s early works and the intersection of gender, identity, and narrative form. She has developed courses exploring themes like alienation in modern literature and the evolution of literary culture in Ireland. Finneran’s pedagogical approach prioritizes student engagement across diverse backgrounds. Publications listed reflect interdisciplinary collaboration in public health and behavioral science, though these appear unrelated to her primary literary focus. These include studies on HIV care interventions, intimate partner violence among sexual minority men, and HPV education. While the connection to her literary expertise is unclear, the listed articles suggest possible parallel research streams or potential data overlap. No formal grants or awards are mentioned in the provided materials. Her professional activities focus on undergraduate education and curriculum development in modernist literature.

• Radiation Oncology
• Cancer Biology
• Molecular Targeted Therapy
• +7 more

Joseph N. Contessa, MD, PhD is an Adjunct Professor of Therapeutic Radiology and Pharmacology at Yale School of Medicine, where he serves as Director of Yale Medicine's Central Nervous System Radiotherapy Program. His clinical practice focuses on treating patients with brain tumors, head and neck cancers, and tumors at the base of the skull, including rare entities such as low-grade and malignant gliomas, ependymomas, high-grade meningiomas, hemangiopericytomas, paragangliomas, and schwannomas. Dr. Contessa's research spans multiple areas of cancer biology with a particular emphasis on molecular mechanisms of therapeutic resistance and novel approaches to radiosensitization. His work explores the role of N-linked glycosylation in cancer progression and treatment resistance, developing small molecule inhibitors targeting this pathway to overcome resistance to EGFR tyrosine kinase inhibitors. He also investigates targeted therapies for head and neck squamous cell carcinoma, molecular imaging of the epidermal growth factor receptor, and drug discovery through high-throughput screening approaches. Analysis of Dr. Contessa's recent publications reveals a consistent focus on the intersection of radiation oncology and molecular biology, particularly examining how glycosylation pathways influence cancer cell response to radiation and targeted therapies. His work spans basic science investigations into protein folding and quality control mechanisms to clinical applications in lung cancer, brain tumors, and head and neck cancers. A significant portion of his research explores how inhibiting specific glycosylation enzymes can sensitize tumors to radiation therapy. Dr. Contessa actively collaborates with leading researchers at Yale including Veronica Chiang (6 publications), Barbara Burtness (2 publications), Kimberly Johung (2 publications), and Scott Gettinger (2 publications). He serves as a Sub Investigator on the clinical trial 'Determining Mechanisms of Sensitivity and Resistance to Anti-Cancer Therapy for Advanced Lung Cancer' (HIC ID 1603017333), which is scheduled for primary completion in June 2026. His laboratory work is closely integrated with clinical care through multiple Yale centers including the Brain Tumor Center, Gamma Knife Center, Head and Neck Cancers Program, and Yale Cancer Center. Dr. Contessa's research bridges basic science discoveries in protein glycosylation with clinical applications in radiation oncology, creating a translational pipeline from bench to bedside for patients with challenging malignancies.

• Health Services Research
• Narrative Interventions
• Hypertension Control
• +3 more

Dr. Jeroan Allison is Chair and Professor at UMass Chan Medical School's Department of Population and Quantitative Health Sciences. Trained as a primary care physician and epidemiologist (Harvard SPH), he leads research in narrative interventions for health behavior change, with continuous funding from NIH, AHRQ, and RWJF. His work spans hypertension control in Vietnam, AI-driven health communication, and implementation science for non-communicable diseases. Harvard School of Public Health: Master of Science in Epidemiology University of Alabama at Birmingham: MD Samford University: BS in Chemistry Research interests include narrative medicine , health disparities , mHealth , and health services research . He has published extensively on hypertension interventions in Vietnam, digital health tools, and tobacco cessation strategies using peer engagement. Recent publications focus on AI applications , global implementation science , and social determinants of health . His team has developed culturally adapted interventions for HPV vaccination and hypertension management using community storytelling methods. Scientific contributions include: Co-Editor-in-Chief of Medical Care Developing simulation-based training for research assistants Designing peer recruitment models for smoking cessation Dr. Allison holds multiple grants and leads the UMMS-Vietnam research collaboration , focusing on late-stage translation research in low-resource settings.

• Pharmacology
• Molecular Biophysics
• Biochemistry
• +8 more

Karen S. Anderson is a Professor of Pharmacology and Molecular Biophysics and Biochemistry at Yale School of Medicine, with a primary appointment in the Department of Pharmacology. She serves as Co-Leader of Developmental Therapeutics at Yale Cancer Center and Co-Director of the Therapeutics/Chemotherapy Program. Dr. Anderson is also an undergraduate research mentor and fellow at Pierson College at Yale, where she advises freshman students. Dr. Anderson's research program focuses on mechanistic enzymology and structure-based drug design to develop novel therapeutics. Her work centers on understanding molecular mechanisms of enzymes that play critical roles in cancer and infectious diseases, including HIV/AIDS. She has made significant contributions to the understanding of HIV reverse transcriptase, anticancer targets like EGFR and HER-2, and enzymes involved in parasitic infections. Her laboratory employs a multidisciplinary approach combining biophysical techniques, structural studies, and computational methods to advance drug discovery. Analysis of her recent publications (2023-2025) reveals a strong research trajectory spanning three main areas: HIV drug resistance and novel inhibitors, cancer therapeutics focusing on resistance mechanisms and targeted therapies, and antiviral/antimicrobial drug development including work on SARS-CoV-2. Her research demonstrates consistent innovation in structure-based drug design approaches across multiple disease areas. Selected Awards and Honors: Enzymes, Coenzymes, & Metabolic Pathways Gordon Research Conference Chair (2001) Yale Cancer Breast Cancer Initiative Research Award (1996) Dean's Young Faculty Award from Yale University (1991) Multiple Monsanto Research Achievement Awards (1985-1989) YWCA Women's Leadership Award (1986-1987) Dr. Anderson has trained over 50 undergraduates, graduate students, M.D./Ph.D. students and postdoctoral fellows who have gone on to successful careers in academia and industry. Her laboratory, the Anderson Lab, focuses on translating mechanistic and structural studies into novel therapeutic approaches for viral infections and cancer. The lab utilizes a range of biophysical techniques to study clinically relevant proteins with the goal of developing more effective therapies for conditions including cancer, infectious diseases, and neurodegenerative disorders.

Rebekah J PrattView profile

Associate Professor

• Health disparities
• Implementation science
• Qualitative research
• +7 more

Rebekah J Pratt serves as an Associate Professor in the Department of Family Medicine and Community Health at the University of Minnesota Medical School. She holds leadership positions as the Screening, Prevention, Etiology & Cancer Survivorship Leader at the Masonic Cancer Center and as an Action Group Leader for Retention and Recruitment at the Center for Women in Medicine and Science. Dr. Pratt earned her PhD from the Centre for Population Health Sciences at the University of Edinburgh. This foundation in population health sciences has shaped her research approach focusing on health equity and community-based interventions. Her research program is centered on addressing health disparities through implementation science and qualitative methodologies. Dr. Pratt specializes in working with immigrant and refugee populations, particularly Somali communities, to improve cancer screening access, vaccine uptake, and other preventive health services. She employs community-engaged research approaches to develop culturally appropriate interventions that address systemic barriers to healthcare. Her work spans multiple domains including cervical cancer screening through HPV self-sampling, tobacco cessation in pediatric settings, food pantry interventions to improve nutrition, and addressing vaccine hesitancy. Dr. Pratt's publication record shows consistent productivity with 98 research outputs documented, including a strong recent output with 14 publications in 2022 and 11 in 2024. Her research demonstrates interdisciplinary collaboration across medicine, public health, and community organizations, with a clear focus on translating research into practice to reduce health disparities. Dr. Pratt has secured significant research funding as both Principal Investigator and Co-Investigator on multiple NIH-funded projects: Principal Investigator for 'Reducing cervical cancer screening disparities in Somali immigrant women through a primary case-based HPV self-sampling intervention' (2021-2026, NIH National Cancer Institute) Co-Investigator on the Cancer Center Support Grant (2024-2029, NIH National Cancer Institute) Co-Investigator on 'Development and Pilot Testing of a mLearning Intervention to Address Sexual Health Needs of Gynecologic Cancer Survivors' (2024-2027, American Cancer Society) Co-Investigator on the 'Genetic Counseling Fellowship in Research Training (GC-FIRST)' (2022-2026, NIH NHGRI) Co-Investigator on the 'Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM)' (2021-2026, National Institute on Minority Health) Dr. Pratt actively collaborates with community organizations serving immigrant populations and works within multiple research centers at the University of Minnesota. Her approach integrates community voices into research design and implementation, focusing on sustainable solutions to health equity challenges. She contributes to both academic medicine through her faculty role and to cancer center initiatives through her leadership in screening and prevention activities.

• Public Health
• Adolescent Health
• HIV Prevention
• +7 more

Susan Davies is an Adjunct Professor in the Department of Health Behavior at the University of Alabama at Birmingham (UAB) School of Public Health. She has held multiple roles, including Professor and Associate Professor at UAB, and has been affiliated with departments such as the Civitan International Research Center and the Nutrition Obesity Research Center (NORC). Her research focuses on public health, adolescent health, HIV prevention, and health disparities. She holds a PhD in Public Health Education from UAB (1997), an M.Ed. in Health Education from George Mason University (1989), and a B.S. in Health and Physical Education from Florida State University (1985). Her research interests include adolescent sexual health, bullying and violence prevention, caregiver communication in pediatric oncology, and interventions targeting marginalized populations such as young African American breast cancer survivors and individuals living with HIV. She has led or contributed to numerous grants funded by the CDC, NIH, and other organizations, including the CHEER Center for the Study of Community Health and interventions targeting CMV prevention in pregnancy and soil-transmitted helminth infections. Dr. Davies has supervised multiple graduate students and taught courses such as Community Assessment, Doctoral Dissertation Research, and Internship Programs. Her work often emphasizes improving healthcare access, reducing disparities, and developing culturally competent interventions. She has been recognized for her contributions to community health and behavioral interventions, though no specific awards are explicitly listed in the provided materials.